Concentrix (CNXC) Competitors

Rentokil Initial (NYSE:RTO) and Concentrix (NASDAQ:CNXC) are both business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability.

Is RTO or CNXC a better dividend stock?

Rentokil Initial pays an annual dividend of $0.66 per share and has a dividend yield of 2.9%. Concentrix pays an annual dividend of $1.33 per share and has a dividend yield of 2.6%. Rentokil Initial pays out 43.7% of its earnings in the form of a dividend. Concentrix pays out 33.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the MarketBeat Community prefer RTO or CNXC?

Concentrix received 21 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 55.32% of users gave Concentrix an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.

Company	Underperform	Outperform
Rentokil Initial	Outperform Votes 5 35.71%	Underperform Votes 9 64.29%
Concentrix	Outperform Votes 26 55.32%	Underperform Votes 21 44.68%

Do analysts prefer RTO or CNXC?

Concentrix has a consensus target price of $69.60, suggesting a potential upside of 36.18%. Given Concentrix's stronger consensus rating and higher probable upside, analysts clearly believe Concentrix is more favorable than Rentokil Initial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rentokil Initial	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.83
Concentrix	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more risk & volatility, RTO or CNXC?

Rentokil Initial has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Concentrix has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.

Which has preferable valuation & earnings, RTO or CNXC?

Rentokil Initial has higher earnings, but lower revenue than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rentokil Initial	$5.44B	2.11	$473.93M	$1.51	15.08
Concentrix	$9.59B	0.34	$251.22M	$3.99	12.81

Is RTO or CNXC more profitable?

Concentrix has a net margin of 2.61% compared to Rentokil Initial's net margin of 0.00%. Concentrix's return on equity of 16.67% beat Rentokil Initial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rentokil Initial	N/A	N/A	N/A
Concentrix	2.61%	16.67%	5.63%

Does the media prefer RTO or CNXC?

In the previous week, Concentrix had 3 more articles in the media than Rentokil Initial. MarketBeat recorded 16 mentions for Concentrix and 13 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.44 beat Concentrix's score of 1.21 indicating that Rentokil Initial is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rentokil Initial	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Concentrix	11 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals have more ownership in RTO or CNXC?

9.9% of Rentokil Initial shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 3.2% of Concentrix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Concentrix beats Rentokil Initial on 14 of the 21 factors compared between the two stocks.